Lindsey Landreneau Whatley, DPT | |
506 Academy Rd Ste 1, Starkville, MS 39759-4022 | |
(251) 455-3685 | |
Not Available |
Full Name | Lindsey Landreneau Whatley |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 10 Years |
Location | 506 Academy Rd Ste 1, Starkville, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144635772 | NPI | - | NPPES |
529917620 | Medicaid | AL | |
1003819608 | Other | AL | GROUP NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT5930 (Mississippi) | Primary |
261QP2000X | Clinic/center - Physical Therapy | PTH7174 (Alabama) | Secondary |
Provider Name | Starkville Peak Performance Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1235811837 PECOS PAC ID: 3971957747 Enrollment ID: O20230927002631 |
News Archive
Low oxygen levels in cells may be a primary cause of uncontrollable tumor growth in some cancers, according to a new University of Georgia study. The authors' findings run counter to widely accepted beliefs that genetic mutations are responsible for cancer growth.
Brenda K. Young, BA, CCRA, senior director of clinical operations at ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, has presented her experience in computerized system validation to the Drug Information Association (DIA) 3rd Annual Clinical Forum held in Nice, France, on October 19, 2009.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.
GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.
Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Lindsey Landreneau Whatley, DPT 506 Academy Rd Ste 1, Starkville, MS 39759-4022 Ph: (251) 455-3685 | Lindsey Landreneau Whatley, DPT 506 Academy Rd Ste 1, Starkville, MS 39759-4022 Ph: (251) 455-3685 |
News Archive
Low oxygen levels in cells may be a primary cause of uncontrollable tumor growth in some cancers, according to a new University of Georgia study. The authors' findings run counter to widely accepted beliefs that genetic mutations are responsible for cancer growth.
Brenda K. Young, BA, CCRA, senior director of clinical operations at ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, has presented her experience in computerized system validation to the Drug Information Association (DIA) 3rd Annual Clinical Forum held in Nice, France, on October 19, 2009.
Researchers from Massachusetts Eye and Ear/Harvard Medical School have found that patients who were prescribed corticosteroids as part of treatment for Lyme disease-associated facial paralysis had worse long-term outcomes of regaining facial function than those who were prescribed antibiotic therapy alone.
GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.
Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.
› Verified 5 days ago
Haley Williams Stevenson, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 513 Academy Rd, Starkville, MS 39759 Phone: 662-268-8013 Fax: 662-268-8095 | |
Jennifer M Deweese, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 210 Turnberry Ln, Starkville, MS 39759 Phone: 662-769-9476 Fax: 662-320-4572 | |
Ashlyn Amy Mendrop, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 225 Tomlinson Dr, Starkville, MS 39759 Phone: 662-328-1012 | |
Dr. Mary Margaret Crowson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Wilburn Way, Starkville, MS 39759 Phone: 662-323-9200 Fax: 662-323-9251 | |
Mrs. Katie Cain Langley, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 610 Yellow Jacket Dr, Starkville, MS 39759 Phone: 662-769-4888 | |
Hilary H Rendon, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 100b4 Gt Thames Drive, Starkville, MS 39759 Phone: 662-615-1870 Fax: 662-615-1871 | |
Haley M Lewis, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 513 Academy Rd, Starkville, MS 39759 Phone: 662-268-8013 Fax: 662-268-8095 |